Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 17/20 | 0.58 |
| ▸ | DRD2 | P14416 | 2/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | HTR1D | P28221 | 1/20 | 0.50 |
| ▸ | HTR1B | P28222 | 1/20 | 0.50 |
| ▸ | HTR1F | P30939 | 1/20 | 0.50 |
| ▸ | HTR7 | P34969 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | IDE | P14735 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7441106 | 0.87 | HTR6 (0.48) | HTR6DRD2HTR1AHTR1DHTR1B | |
| SCHEMBL7433688 | 0.87 | HTR6 (0.58) | HTR6DRD2HTR1AHTR1DHTR1B | |
| SCHEMBL7436733 | 0.85 | HTR6 (0.57) | HTR6DRD2HTR1AHTR1DHTR1B | |
| SCHEMBL7430619 | 0.83 | HTR6 (0.60) | HTR6DRD2HTR1AHTR1DHTR1B | |
| SCHEMBL8689013 | 0.79 | HTR6 (0.68) | HTR6DRD2HTR1AHTR1DHTR1B | |
| SCHEMBL7443109 | 0.78 | HTR6 (0.61) | HTR6DRD2HTR1AHTR1DHTR1B | |
| SCHEMBL946691 | 0.76 | HTR6 (0.75) | HTR6DRD2HTR1AHTR1DHTR1B | |
| Oxalic Acid SCHEMBL7433702 | 0.76 | HTR6 (0.90) | HTR6DRD2HTR1AHTR1DHTR1B | |
| SCHEMBL838015 | 0.75 | HTR6 (0.64) | HTR6IDE | |
| SCHEMBL838017 | 0.75 | HTR6 (0.64) | HTR6IDE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6187805-B1 | TREATING CONDITION FOR WHICH SELECTIVE AGONISM OR ANTAGONISM OF 5-HT-6 RECEPTORS IS INDICATED BY ADMINISTERING COMPOUNDS SUCH AS N,N-DIMETHYL 2-(1-(BENZENESULPHONYL)-5-METHOXY-1H-INDOL-3-YL)ETHYLAMINE | MERCK SHARP & DOHME LTD. (GB) | 2001-02-13 | — | — | US | disclosed |